These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9191824)

  • 1. The COBE Spectra cell separator is more effective than the Haemonetics MCS-3P cell separator for peripheral blood progenitor cell harvest after mobilization with cyclophosphamide and filgrastim.
    Morton JA; Baker DP; Hutchins CJ; Durrant ST
    Transfusion; 1997 Jun; 37(6):631-3. PubMed ID: 9191824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective, concurrent comparison of the Cobe Spectra and Haemonetics MCS-3P cell separators for leukapheresis after high-dose filgrastim in patients with hematologic malignancies.
    Mehta J; Powles R; Treleaven J; Millar B; Proctor H; Cabral S; Shepherd V; Singhal S
    J Clin Apher; 1997; 12(2):63-7. PubMed ID: 9263112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective randomised comparison of the COBE spectra version 6 and haemonetics MCS(+) cell separators for hematopoietic progenitor cells leucapheresis in patients with multiple myeloma.
    Abdelkefi A; Maamar M; Torjman L; Ladeb S; Lakhal A; Ben Othman T; Slama H; Jenhani F; Mojaat N; Ben Hamed L; Bouhoula S; Hsairi M; Boukef K; Ben Abdeladhim A
    J Clin Apher; 2006 Jul; 21(2):111-5. PubMed ID: 16395725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of intermittent- and continuous-flow cell separators for the collection of autologous peripheral blood progenitor cells in patients with hematologic malignancies.
    Hitzler WE; Wolf S; Runkel S; Kunz-Kostomanolakis M
    Transfusion; 2001 Dec; 41(12):1562-6. PubMed ID: 11778073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective randomised concurrent comparison of the COBE Spectra Version 4.7, COBE Spectra Version 6 (auto PBSC) and Haemonetics MCS+ cell separators for leucapheresis in patients with haematological and non-haematological malignancies.
    Green RH; Watson D; Buchanan S; Morrison AE
    Transfus Apher Sci; 2001 Feb; 24(1):85-90. PubMed ID: 11515616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Cobe Spectra and Haemonetics MCS-3P cell separators for peripheral blood stem cell harvesting.
    Mehta J; Powles R; Cabral S; Shepherd V; Singhal S; Morilla R; Treleaven J
    Bone Marrow Transplant; 1995 Nov; 16(5):707-9. PubMed ID: 8547869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective randomised concurrent comparison of the COBE spectra version 4.7, COBE spectra version 6 (Auto PBSCtrade mark), and haemonetics MCS+ cell separators for leucapheresis in patients with haematological and non haematological malignancies.
    Morrison AE; Watson D; Buchanan S; Green RH
    J Clin Apher; 2000; 15(4):224-9. PubMed ID: 11124689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization.
    Passos-Coelho JL; Braine HG; Davis JM; Huelskamp AM; Schepers KG; Ohly K; Clarke B; Wright SK; Noga SJ; Davidson NE
    J Clin Oncol; 1995 Mar; 13(3):705-14. PubMed ID: 7533827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a novel automated protocol for the collection of peripheral blood stem cells mobilized with chemotherapy or chemotherapy plus G-CSF using the Fresenius AS104 cell separator.
    Pierelli L; Menichella G; Paoloni A; Vittori M; Foddai ML; Serafini R; Rumi C; Mitschulat H; Rossi PL; Scambia G
    J Hematother; 1993; 2(2):145-53. PubMed ID: 7522877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of G-CSF on peripheral blood progenitor cell mobilization and collection from healthy donors.
    Chaisiripoomkere W; Jootar S; Ungkanont A
    Asian Pac J Allergy Immunol; 2001 Sep; 19(3):183-90. PubMed ID: 11826913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of the effect of Cobe Spectra and Fenwal CS 3000 plus blood cell separators in collection of peripheral blood stem cell components].
    Yang SM; Liu KY; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):245-9. PubMed ID: 15854285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF.
    Cesana C; Carlo-Stella C; Regazzi E; Garau D; Sammarelli G; Caramatti C; Tabilio A; Mangoni L; Rizzoli V
    Bone Marrow Transplant; 1998 Mar; 21(6):561-8. PubMed ID: 9543059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole blood harvested after granulocyte-colony stimulating factor (Neupogen) mobilization, and reinfused unprocessed after high-dose melphalan treatment, accelerates hematopoietic recovery in patients with multiple myeloma.
    Raina V; Sharma A; Kumar R; Bhargava M
    Cancer; 1996 Mar; 77(6):1073-8. PubMed ID: 8635126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term hematopoietic engraftment after autologous peripheral blood progenitor cell transplantation in pediatric patients: effect of the CD34+ cell dose.
    Diaz MA; Vicent MG; Garcia-Sanchez F; Vicario JL; Madero L
    Vox Sang; 2000; 79(3):145-50. PubMed ID: 11111232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
    Weaver CH; Schulman KA; Buckner CD
    Bone Marrow Transplant; 2001 May; 27 Suppl 2():S23-9. PubMed ID: 11436117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective randomized trial of two popular mononuclear cell collection sets for autologous peripheral blood stem cell collection in multiple myeloma.
    Cooling L; Hoffmann S; Herrst M; Muck C; Armelagos H; Davenport R
    Transfusion; 2010 Jan; 50(1):100-19. PubMed ID: 19719472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF.
    Koç ON; Gerson SL; Cooper BW; Laughlin M; Meyerson H; Kutteh L; Fox RM; Szekely EM; Tainer N; Lazarus HM
    J Clin Oncol; 2000 May; 18(9):1824-30. PubMed ID: 10784622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells.
    Stroncek DF; Clay ME; Petzoldt ML; Smith J; Jaszcz W; Oldham FB; McCullough J
    Transfusion; 1996 Jul; 36(7):601-10. PubMed ID: 8701455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing peripheral blood stem cell collection using the COBE Spectra, Haemonetics MCS+, and Baxter Amicus.
    Wu FY; Heng KK; Salleh RB; Soh TG; Lee JJ; Mah J; Linn YC; Loh Y; Hwang W; Tan LK; Law P; Goh YT
    Transfus Apher Sci; 2012 Dec; 47(3):345-50. PubMed ID: 23032067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in blood counts after the administration of granulocyte-colony-stimulating factor and the collection of peripheral blood stem cells from healthy donors.
    Stroncek DF; Clay ME; Smith J; Ilstrup S; Oldham F; McCullough J
    Transfusion; 1996 Jul; 36(7):596-600. PubMed ID: 8701454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.